Table 3.

Characteristics of the patients who were referred to intensive care units (ICUs), and those exited

Patients, n	Concordance to EAT	Age (year)/gender	Agent	The state of resistance	Concomitant disease	Outcome
1	Concordant	81/Female	K. pneumonia	ESBL producing	None	Exitus
2	Discordant	98/Male	Enterococcus faecalis	Susceptible to penicilline	None	ICU
3	Discordant	49/Male	K. pneumonia	Resistant to all antibiotics	Bladder carcinoma	Exitus
4	Discordant	69/Male	K. pneumonia	Carbapenemase	DM, cardiovascular disease	ICU
5	Discordant	83/Female	E. coli	ESBL producing	DM	Exitus

ESBL: extended–spectrum beta-lactamase; EAT: empirical antibiotherapy; DM: diabetes mellitus; ICU: intensive care unit